PPT-Pharmacovigilance and drug safety trainings to increase Tuberculosis (TB) preventive treatment

Authors 1 Juliet Jokwiro 1 Nicole ChekudambuneKawaza 1 Kenny Sithole 1 Bongani Dube 2 Charles Sandy 2 Manners Ncube 2 Regina Mubau 2 Chlorata Gwanzura 2 Kwenziweyinkosi Ndlovu . New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Why do we test?. 1. We want to prevent an outbreak of Tuberculosis in our campus community. 2. We want to find those that are affected and get them treated so you are able to continue to participate in your schooling. . JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepidemiology. Pharmacovigilance. JAMASOFT2017. 2. P. armacovigilance. system collects data . throughout the . lifecycle . of each . medicinal. . product. Treatment of Latent . Tuberculosis Infection and Tuberculosis. Disease . Module 4 – Treatment of Latent Tuberculosis Infection and Tuberculosis Disease. 2. Module 4: Objectives. At completion of this module, learners will be able to:. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Coordinator RSS. N Dellepiane. Prospects and Challenges of Providing Pharmacovigilance Services in Resource Limited Countries Avong YK 1 , Jatau B 1 , Ekong E 1 , Ndembi N 1 , Okuma J 1 , Obieze AI 2 , Osakwe A 2 , 1466 Nikhil GuptaKavita BahmaniAjit Jangra IntroductionPharmacovigilance and drug safety remains As per the World Health Organization (WHO), Pharmacovigilance may be dened ClinicalPractice ISSN Courses in Therapeutics and Disease State Management. Learning Objectives (Slide 1 of 2). Identify the risk factors for TB infection and active disease.. Design an appropriate therapeutic plan for latent tuberculosis in immunocompetent, immunocompromised, and special patient populations.. symposium . IAS 2019-Mexico. Monday, July 22nd July, 2019. Lucia González Fernández, IAS, Geneva. PROCESS OF CARE. QUALITY IMPACT. POPULATION. GOVERNANCE. PLATFORMS. PROVIDERS. TOOLS. FOUNDATIONS. 2 Months. Staff and Treatment Supporters. Earlier, TB Preventive Therapy (TPT) workflows on Ni-kshay were triggered by six specific risk factors, which were 'Contact of TB Patients', 'Patient on immunosuppressants', 'Silicosis', 'Anti-TNF treatment', 'Dialysis', and 'Transplantation'. In 2023-24, the program prioritized institution-based mapping of other risk groups for TPT by districts. To ensure that all eligible individuals receive preventive treatment, the list of triggers for TPT workflows has been updated on Ni-kshay to include all risk factors, including HIV status to be either positive or reactive. . Shah N, Richardson J, Moodley P, Moodley S, Babaria P, Ramtahal M, et al. Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa. Emerg Infect Dis. 2011;17(3):510-513. https://doi.org/10.3201/eid1703.101363. Malik AA, Gandhi NR, Lash TL, Cranmer LM, Omer SB, Ahmed JF, et al. Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan. Emerg Infect Dis. 2021;27(3):805-812. https://doi.org/10.3201/eid2703.203916. Dr. Sonalika’s Eye Clinic provide the best Eye infection treatment, Conjunctivitis treatment in pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri Dr. Sonalika’s Eye Clinic provide the best Conjunctivitis (Pink Eye) treatment in Pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri